Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-281 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. With this NOFO, the NCI intends to encourage submission of projects devoted to demonstrating that mammalian models or their derivatives used for translational research are robust representations of human biology, are appropriate to test questions of clinical importance, and provide reliable information for patients'...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 18, 2023 Category: Research Source Type: funding
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-244 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol and cancer risk, understanding and changing social norms related to alcohol consumption, developing and/or evaluating alcohol policy approaches, and the development, testing, and implementation of population-level interventions to reduce alcohol-related cancer risk. Applications that address multiple levels of consumption, such as moderate and heavy drinking, are of particular i...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 15, 2023 Category: Research Source Type: funding
Notice of Pre-Application Webinar for PAR-23-273: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Notice NOT-CA-23-083 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 15, 2023 Category: Research Source Type: funding
Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
Funding Opportunity PAR-23-273 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) is intended to support mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including ones response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental, a...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2023 Category: Research Source Type: funding
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-264 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits applications for identification of small molecules that function to elucidate the biology of disease as chemical probes or function as agonists or antagonists of disease target(s) for therapy or immunotherapy. The NOFO is intended to support discovery research for the identification of validated hits relevant to health-related outcomes of participating NIH Institutes. Stages of discovery research covered by this NOFO include: 1) assay development for ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 10, 2023 Category: Research Source Type: funding
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-243 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investiga...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2023 Category: Research Source Type: funding
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-242 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for laboratory-based scientists.The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investiga...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 9, 2023 Category: Research Source Type: funding
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
Funding Opportunity PAR-23-259 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developments in imaging, data science and/or spectroscopic technologies into methods or tools that address contemporary problems in understanding the fundamental biology, potential risk of development, diagnosis, treatment, and/or disease status for cancer or other disease. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 8, 2023 Category: Research Source Type: funding
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-254 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clini...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2023 Category: Research Source Type: funding
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Funding Opportunity PAR-23-255 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clini...
Source: NIH Funding Opportunities (Notices, PA, RFA) - August 1, 2023 Category: Research Source Type: funding
Notice of Pre-application Webinar for RFA-CA-23-036: Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers; U01 Clinical Trials Not Allowed and RFA-CA-23-037: Next Generation Chemistry Centers for Fusion Oncoproteins; UM1 Clinical Trial Not Allowed
Notice NOT-CA-23-080 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 26, 2023 Category: Research Source Type: funding
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-246 from the NIH Guide for Grants and Contracts. Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. Proposed projects should address major barriers in cancer biology and/or oncology using nanotechnology and should emphasize mechanistic studies toward fundamental understanding of nanomaterial and/or nanodevice interactions with biological systems. These studies should be performed in context of research concerning the delivery of n...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2023 Category: Research Source Type: funding
Next Generation Chemistry Centers for Fusion Oncoproteins (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-037 from the NIH Guide for Grants and Contracts. NCI is forming the Targeting Fusion Oncoproteins in Childhood Cancers (TFCC) Network to advance our understanding of the mechanisms of action of fusion oncoproteins in pediatric cancers and to apply novel chemical strategies for developing targeted therapeutic approaches. This RFA will use the UM1 mechanism to fund Next Generation Chemistry Centers (NGC) for Fusion Oncoproteins that have independent research projects using innovative chemical biology technologies and chemoproteomic approaches to target fusion-driven cancers. The goal of these...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2023 Category: Research Source Type: funding
Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-036 from the NIH Guide for Grants and Contracts. NCI is forming the Targeting Fusion Oncoproteins in Childhood Cancers (TFCC) Network to advance our understanding of the mechanisms of action of fusion oncoproteins in pediatric cancers and to apply novel chemical strategies for developing targeted therapeutic approaches. This RFA will use the U01 mechanism to solicit applications focused on molecular mechanisms by which fusion oncoproteins drive pediatric cancers with the goals of better understanding the biology of these cancers and identifying potential drug targets or critical dependencie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 17, 2023 Category: Research Source Type: funding
Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"
Notice NOT-CA-23-077 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 10, 2023 Category: Research Source Type: funding
